COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
出版年份 2020 全文链接
标题
COVID‐19 in multiple sclerosis patients: susceptibility, severity risk factors and serological response
作者
关键词
-
出版物
EUROPEAN JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
出版商
Wiley
发表日期
2020-12-19
DOI
10.1111/ene.14690
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis
- (2020) Brandon Michael Henry et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California
- (2020) Kristen M. J. Azar et al. HEALTH AFFAIRS
- Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis
- (2020) Jing Yang et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review
- (2020) Chiara Minotti et al. JOURNAL OF INFECTION
- How will country-based mitigation measures influence the course of the COVID-19 epidemic?
- (2020) Roy M Anderson et al. LANCET
- Antibody responses to SARS-CoV-2 in patients with COVID-19
- (2020) Quan-Xin Long et al. NATURE MEDICINE
- Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York
- (2020) Rebecca Haberman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin-D and COVID-19: do deficient risk a poorer outcome?
- (2020) Fiona Mitchell Lancet Diabetes & Endocrinology
- COVID-19 and MS disease-modifying therapies
- (2020) Joseph R. Berger et al. Neurology-Neuroimmunology & Neuroinflammation
- Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study
- (2020) Marina Pollán et al. LANCET
- An Italian programme for COVID-19 infection in multiple sclerosis
- (2020) Maria Pia Sormani LANCET NEUROLOGY
- Keeping standards of multiple sclerosis care through the COVID-19 pandemic
- (2020) Jaume Sastre-Garriga et al. Multiple Sclerosis Journal
- Multiple sclerosis management during the COVID-19 pandemic
- (2020) Brandon P Moss et al. Multiple Sclerosis Journal
- Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study
- (2020) Amit Bar-Or et al. NEUROLOGY
- Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis
- (2020) Céline Louapre et al. JAMA Neurology
- Infections in patients diagnosed with multiple sclerosis: A multi-database study
- (2020) R. Persson et al. Multiple Sclerosis and Related Disorders
- The underpinning biology relating to multiple sclerosis disease modifying treatments during the COVID-19 pandemic
- (2020) David Baker et al. Multiple Sclerosis and Related Disorders
- B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
- (2020) Farinaz Safavi et al. Multiple Sclerosis and Related Disorders
- Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
- (2020) Paloma Montero-Escribano et al. Multiple Sclerosis and Related Disorders
- Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
- (2020) Takuya Sekine et al. CELL
- COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
- (2020) Virginia Meca-Lallana et al. Multiple Sclerosis and Related Disorders
- The REDCap consortium: Building an international community of software platform partners
- (2019) Paul A. Harris et al. JOURNAL OF BIOMEDICAL INFORMATICS
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Defining the clinical course of multiple sclerosis: The 2013 revisions
- (2014) F. D. Lublin et al. NEUROLOGY
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started